These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1981485)

  • 21. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the rat: characterization and age-dependent effects.
    Jarvis MF; Wagner GC
    Synapse; 1990; 5(2):104-12. PubMed ID: 2309157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in goldfish cerebellum: neurochemical and immunocytochemical analysis.
    Lucchi R; Notari S; Pierantozzi S; Barnabei O; Villani L; Poli A
    Brain Res; 1998 Jan; 782(1-2):105-12. PubMed ID: 9519254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin attenuates MPTP-induced dopaminergic neuronal injury associated with scavenging hydroxyl radical.
    Li XJ; Gu J; Lu SD; Sun FY
    J Pineal Res; 2002 Jan; 32(1):47-52. PubMed ID: 11841600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The acute histopathology of MPTP in the mouse CNS.
    Adams JD; Kalivas PW; Miller CA
    Brain Res Bull; 1989; 23(1-2):1-17. PubMed ID: 2804701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G; Nwanze E; Luthman J; Sundström E
    Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotoxicity of an MPTP analogue, 2'CH3-MPTP, on monoaminergic systems in the mouse brain.
    Gupta M; Chen XL
    Ann N Y Acad Sci; 1992 May; 648():283-5. PubMed ID: 1353331
    [No Abstract]   [Full Text] [Related]  

  • 28. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
    J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible effects of 1-methyl-4-phenylpyridinium ion (MPP(+)) on dopaminergic neurons in goldfish retina.
    Poli A; Gandolfi O; Roncada P; Guarnieri T; Lucchi R; Villani L
    Neurochem Int; 1989; 15(2):223-6. PubMed ID: 20504487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    O'Callaghan JP; Miller DB; Reinhard JF
    Brain Res; 1990 Jun; 521(1-2):73-80. PubMed ID: 1976416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in prenatal stage on the dopamine system in the postnatal mouse brain.
    Ochi N; Naoi M; Mogi M; Ohya Y; Mizutani N; Watanabe K; Harada M; Nagatsu T
    Life Sci; 1991; 48(3):217-23. PubMed ID: 1671518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP.
    Pollard HB; Dhariwal K; Adeyemo OM; Markey CJ; Caohuy H; Levine M; Markey S; Youdim MB
    FASEB J; 1992 Sep; 6(12):3108-16. PubMed ID: 1521741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MPTP induces neurodegeneration by modulating dopaminergic activity in catfish brain.
    Sajwan-Khatri M; Senthilkumaran B
    Neurotoxicol Teratol; 2023; 95():107146. PubMed ID: 36481438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative studies of the neurotoxicity of MPTP in rats of different ages.
    Lee EH; Liu SP; Lu KT; Lin WR
    Chin J Physiol; 1992; 35(4):317-36. PubMed ID: 1364057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Features of the dopaminergic neurotoxin MPTP.
    Kopin IJ
    Ann N Y Acad Sci; 1992 May; 648():96-104. PubMed ID: 1637076
    [No Abstract]   [Full Text] [Related]  

  • 36. Histochemical localization of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine oxidation in the mouse brain.
    Vincent SR
    Neuroscience; 1989; 28(1):189-99. PubMed ID: 2569695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
    Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
    Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
    Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice.
    Blanchet J; Longpré F; Bureau G; Morissette M; DiPaolo T; Bronchti G; Martinoli MG
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1243-50. PubMed ID: 18471948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
    Alam G; Edler M; Burchfield S; Richardson JR
    Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.